Ahụ ike, Preparations
"Biseptol" site na ihe na-enyere aka? Ọ ga-ekwe omume na-emeso bronchitis, ụkwara, cystitis na "Biseptol"?
Pụtara "Biseptol" - a Nchikota ọgwụ ọjọọ na-emegide nje Njirimara. O mere ka Polish emepụta ọgwụ na ụlọ ọrụ "Polfa" na wepụtara nanị pharmacies site ọgwụ.
Hapụ ụdị ọgwụ "Biseptol"
The agwọ ọrịa arụpụtara ke ọtụtụ ụzọ dị iche iche: n'ụdị mbadamba 120 mg na 480 mg, maka onu nkwusioru na 80 ml nke uche na vials nke 8 ml. N'agbanyeghị nke ntọhapụ ụdị, nkwadebe nwere isi ihe abụọ na mmiri: sulfamethoxazole na trimethoprim (400 mg na 80 mg, karị). The nkwusioru na-agbala maka ụmụaka na nwere obi ụtọ ụtọ uto. E wezụga n'ọrụ Efrata, ọ na-emi esịnede Cremophor RH 40, sodium nnu nke carboxymethylcellulose, magnesium aluminum silicate, citric acid, sodium hydrogen phosphate, maltitol, propyl hydroxybenzoate, methyl hydroxybenzoate, propylene glycol, ọcha mmiri. The ampoules na-eji nanị maka ọgwụgwọ n'ụlọ ọgwụ. Ha, dị ka nkwusioru nwere, e wezụga isi ihe abụọ arụsi ọrụ ike, ihe ngwa components: propylene glycol, sodium hydroxide, benzyl mmanya, ethanol, sodium pyrosulfate na mmiri ogwu ogbugba. Mbadamba dị gburugburu ewepụghị udi, na-acha ọcha-acha agba na osise "Bs". E wezụga n'ọrụ Efrata iso nke nduku starch, talc, magnesium stearate, mmanya polyvinyl na ndị ọzọ na mmiri.
pharmacological mmetụta
Ọgwụ "Biseptol" nwere a bacteriostatic utịp ke iche iche nke pathogens. Sulfamethoxazole akpaghasị metabolism na bacteria, gụnyere egbochi njikọ nke dihydrofolic acid n'ime ha mkpụrụ ndụ. Trimethoprim egbochi nucleic asịd dị mkpa maka ibu na mmeputakwa nke microorganisms, nke na-eduga ha ngwa ngwa onwu. The ifịk ifịk mmiri nke mbadamba "Biseptolum" etinye obi gị dum na obere eriri afọ. Ha banye n'ime n'ime ọmụmụ na anụ ahụ nke ahụ: na akụrụ, akpa ume, tonsils, prostate, na mmamiri na bronchial secretion. Sulfamethoxazole na trimethoprim na-gabiga placental mgbochi na n'oge lactation nwere ike anyụpụ na mmiri ara. Mgbe minit 60 mgbe na-ewere ọgwụ ịta nke nọ n'ọrụ bekee na ọbara esịmde a ịgba uru. The ọgwụgwọ mmetụta dịruru maka 12 awa. Nkwadebe ewepụtara organism n'ime 10-12 awa, ọkacha mma mmamịrị. Ya mere, anyị na-ele anya na ihe mmetụta ọgwụ nwere "Biseptol". Site na ihe na-enyere ya, anyị ga-anọgide na.
Mgbe ụfọdụ, ndị dọkịta idepụta ọgwụ "Biseptol"?
The ọgwụ ebibi dị iche iche gram-adịghị mma na gram-mma bacteria na ọbụna ụfọdụ pathogenic dịkwa ka usoro ha. Ọ bụ irè megide dị otú ahụ pathogens ka Haemophilus influenzae, Escherichia coli, klebsiela, Proteus, Enterobacter, Morganella, streptococcus, Salmonella, Legionella, Toxoplasma, Neisseria. Ọ bụkwa n'ọrụ megide chlamydia na ọrịa ọgbụgbọ na ọnyụnyụ. A dịgasị iche iche nke pathogenic microorganisms nke ndị chọrọ nlezianya na-arụsi ọrụ ike mgbagwoju nke sulfamethoxazole na trimethoprim, na-akpata otu nnukwu ndepụta nke ọrịa na nke ọgwụ na-kenyere "Biseptolum". Site na ihe na-enyere ya? Ọtụtụ mgbe, ndị na ngwá ọrụ na-eji maka ọgwụgwọ nke nnukwu akụkụ okuku ume na tract nje (pharyngitis, tonsillitis, oyi baa, bronchiolitis), na-efe efe nke elu akụkụ okuku ume na tract (otitis, ala ala Sinusitis). Ọtụtụ mgbe, ndị dọkịta idepụta ọgwụ "Biseptol" si bronchitis mere site bacteria. Ọ bụ uru na-echeta na Ịzụ na-eji ọgwụ na-enweghị a dọkịta gwara nwere ike ịbụ onye ahụ nke ụkwara. Bronchitis nwere ike mere site na ọ bụghị nanị na bacteria kamakwa nje na-eguzogide ọgwụ mbadamba mmiri. Ghara imerụ gị ahụ, ọgwụ "Biseptol" ụkwara kwesịrị iwere nanị mgbe a nleta a therapist. Self-ọgwụgwọ bụ adịghị anakwere.
Gịnị ka "Biseptol" mkpụrụ ọgwụ aka?
Ego na-na-eji na-emeso urinary tract na Genital akụkụ. Ọma na ọ bụ ọnụnọ nke urethritis, gụnyere postgonoreynogo, gonococcal ọrịa, pielita, ala ala pyelonephritis, prostatitis. Ọtụtụ mgbe e kenyere nkwadebe "Biseptol" cystitis. All okwu ahụ bụ na ọ fọrọ nke nta 80% nke ikpe ihe na-akpata ọrịa na urinary tract na mbufụt nke eriri afo bụ E. coli. Mbadamba "Biseptol" akwa mgba na a nje.
O sina dị, ọ bụ uru na-echeta na na ọgwụgwọ nke urinary tract-efe efe ga-eduzi ndị na-atụ aro nke dọkịta gị. Ọ eleghị anya na-ekenye gị a Erere "Biseptol" na fluoroquinolone ude. Erughị eru ọgwụgwọ na onwe-ọgwụ nwere ike ime ka ala ala urinary tract-efe efe, nke nwere oké ike na-emeso. E wezụga cystitis ọgwụ "Biseptol" na-enyere na ọnụnọ nke eriri afọ na-efe efe: ịba ahụ ọkụ, bacillary ọnyụnyụ ọbara, paratyphoid, ọrịa ọgbụgbọ na ọnyụnyụ. Ọ bụ irè n'iru adụ anụ ahụ na-efe efe na akpụkpọ dị ka abrasions, pyoderma ma ọ bụ etuto. Mgbe ụfọdụ, ndị dọkịta ji nye iwu na ọgwụgwọ nke meningitis ọgwụ "Biseptol". Site na ihe na-enyere ya, anyị na-enyocha. Ọzọ, anyị na-akọwa na ngwa nke atụmatụ nakwa dị ka agwa banyere contraindications na o kwere omume mmetụta nke ọgwụ.
Ntuziaka maka ojiji. onunu ogwu
Na oge nke ọgwụgwọ na-ekpebisi ike maka onye ọ bụla ndidi n'otu n'otu. Ọ nwere ike na mbio 5 14 ụbọchị. Na-emekarị a kwa ụbọchị usoro onunu ogwu nke ọgwụ gbakọọ dị ka ndị a: 30 mg nke sulfamethoxazole na trimethoprim 6 mg kwa 1 n'arọ nke ahu aro. Infants prescribers "Biseptolum" n'ụdị nkwusioru ma ọ bụ sirop. Ọkọlọtọ onunu ogwu maka ụmụaka bụ ka ndị a:
- si 3 6 ọnwa - 2,5 ml (ọ bụla 12 awa);
- noo si 7 ọnwa na afọ 3 - 2.5-5 ml;
- noo 4 6 afọ - 5,10 ml;
- n'agbata afọ 7 ruo 12 afọ - 10 ml.
Children 12 afọ na ndị okenye, na ndị okenye mkpa ka a etinyere 20 ml 12 ọ bụla awa. Mgbe na-ekenye mbadamba "Biseptolum" ọrịa na-enwe gbasara akụrụ odida, na onunu ogwu na-belata ọkara.
Contraindications na mmetụta nke ọgwụ "Biseptol"
Ọ na-contraindicated na ọrịa ndị na-kwuputela malfunction nke akụrụ na hemopoietic usoro. Ọ bụghị na-atụ aro iji ọgwụ "Bispetol" ndị mmadụ na folic acid erughi, na-enwe uche na ifịk ifịk mmiri (trimethoprim na / ma ọ bụ sulfonamides). Ọ na-adịghị họpụtara ụmụ obere karịa ọnwa 3, n'oge ime na lactation. Na ruo ogologo oge na-achịkwaghị achịkwa na-ewere ọgwụ "Biseptol" nwere ike imetụta ahụ ike, gụnyere ndị na-akpata ọgbụgbọ, vomiting, afọ ọsịsa, mgbu. Na obere okwu ndị nwere ike na-akwalite ọdịdị nke ịba ọcha n'anya, nnukwu imeju necrosis, pancreatitis. Ọzọkwa, oriri nke mbadamba nkume nwere ike ime na nfụkasị Jeremaya: aṅụ, itchy akpụkpọ ma ọ bụ ihe ọkụ ọkụ.
Similar articles
Trending Now